Sort
64,565 grants matching “drug discovery”
The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network
$1,731,705William E. Carson · Ohio State University · UM1 · FY2025 · CA
The roles of lipid mediators in inflammation, pain, and neuro-degeneration
$1,731,681Christopher Ramsden · National Institute On Aging · ZIA · FY2018 · AG
Drug Induced Liver Injury Network Data Coordinating Center
$1,730,418Huiman X Barnhart · Duke University · U01 · FY2025 · DK
Subcellular protein localization in B. subtilis
$1,730,255Kumaran Ramamurthi · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease
$1,729,411Clinton H. Joiner · Emory University · U01 · FY2014 · HL
RP5: Chemical proteomic discovery of small-molecule probes for autophagy proteins
$1,729,091Benjamin F Cravatt · Ut Southwestern Medical Center · U19 · FY2023 · AI
Human Disease-Specific Induced Pluripotent Stem Cells For Preclinical Drug Testing and Drug Discovery
$1,728,439Lynne A Bui · Khloris Biosciences, Inc. · R44 · FY2022 · HL
Novel Antagonists of the N-terminal Domain of the CRF Receptor Type 1 for Alzheimer's Disease
$1,728,235Robert A Rissman · Veterans Medical Research Fdn/San Diego · RF1 · FY2020 · AG
Molecular And Pharmacological Studies Of Dopamine Receptors
$1,728,156David Sibley · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
Assay development and screening for molecular targets and discovery
$1,728,139Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Telomere Biology
$1,727,803Julia Cooper · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies
$1,727,315Michael A. Carducci · Johns Hopkins University · UM1 · FY2024 · CA
The Partnership for Native American Cancer Prevention (1 of 2)
$1,727,232Laura F. Huenneke · Northern Arizona University · U54 · FY2010 · CA
Telomere Biology
$1,726,427Julia Cooper · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis
$1,726,316Gregory Paul Downey · National Jewish Health · UH3 · FY2020 · TR
Clinical Research Support for the CCR
$1,726,298Robert Wiltrout · Division Of Basic Sciences - Nci · ZID · FY2013 · CA
Resolving the bottleneck in antibiotic discovery
$1,726,091Kim Lewis · Northeastern University · P01 · FY2019 · AI
Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe)
$1,725,519Michael Benatar · University Of Miami School Of Medicine · U54 · FY2019 · NS
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
$1,725,172Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2010 · RR
Targeting RNA Binding and Nuclear Export of HIV Rev
$1,725,109Scripps Research Institute · P01 · FY2005 · GM
Discovery of Adjuvants that Direct T-cell Fates for Improved Safety and Efficacy in Vaccines Against Influenza and Tuberculosis
$1,724,791Aaron Esser-Kahn · University Of Chicago · N01 · FY2025 · AI
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
$1,723,236Jeremy Goecks · Oregon Health & Science University · U2C · FY2021 · CA
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
$1,722,942Robert C Bast · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network
$1,722,607William E. Carson · Ohio State University · UM1 · FY2023 · CA
BRITE-Eye: An integrated discovery engine for CNS therapeutic targets driven by high throughput genetic screens, functional readouts in human neurons, and machine learning
$1,721,943Luis Alberto Williams · Quiver Bioscience Inc. · R44 · FY2023 · MH